Bo Zhang

Bo Zhang

Auto-generated profile, based on publicly available information

Bo Zhang

Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xi’an, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2025 in Science
Verified
Journal Article
Closed access
MLMengyao Li
Mengyao Li
ZJZhenhuan Jiang
Zhenhuan Jiang
XXXueqiang Xu
Xueqiang Xu
XWXinglong Wu
Xinglong Wu
YLYun Liu
Yun Liu
FTFuchou Tang
Fuchou Tang
In mammals, fertilized eggs undergo genome-wide epigenetic reprogramming to generate the organism. However, our understanding of epigenetic dynamics during preimplantation development at single-cell resolution remains incomplete. Here, we developed scNanoATAC-seq2, a single-cell assay for transposase-accessible chromatin using long-read sequencing for scarce samples. We present a detailed chromatin accessibility landscape of mouse preimplantation development, revealing distinct chromatin signatures in the epiblast, primitive endoderm, and trophectoderm during lineage segregation. Differences between zygotes and two-cell embryos highlight reprogramming in chromatin accessibility during the maternal-to-zygotic transition. Single-cell long-read sequencing enables in-depth analysis of chromatin accessibility in noncanonical imprinting, imprinted X chromosome inactivation, and low-mappability genomic regions, such as repetitive elements and paralogs. Our data provide insights into chromatin dynamics during mammalian preimplantation development and lineage differentiation.

20 February 2024 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
BZBo Zhang
Bo Zhang
ZQZechao Qu
Zechao Qu
HHHua Hui
Hua Hui
BHBaorong He
Baorong He
DWDong Wang
Dong Wang
LYliang yan
liang yan
Background: Isoorientin (ISO) is a glycosylated flavonoid with antitumor, anti-inflammatory, and antioxidant properties. However, its effects on bone metabolism remain largely unknown. Methods: In this study, we aimed to investigate the effects of ISO on receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation in vitro and bone loss in post-ovariectomy (OVX) rats, as well as to elucidate the underlying mechanism. First, network pharmacology analysis indicated that MAPK1 and AKT1 may be potential therapeutic targets of ISO and that ISO has potential regulatory effects on the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathways, as well as oxidative stress. ISO was added to RAW264.7 cells stimulated by RANKL, and its effects on osteoclast differentiation were evaluated using tartrate‐resistant acid phosphatase (TRAP) staining, TRAP activity measurement, and F-actin ring analysis. Reactive oxygen species (ROS) production in osteoclasts was detected using a ROS assay kit. The effects of ISO on RANKL-triggered molecular cascade response were further investigated by Western blotting, quantitative real-time polymerase chain reaction, and immunofluorescence staining. In addition, the therapeutic effects of ISO were evaluated in vivo. Results: ISO inhibited osteoclastogenesis in a time- and concentration-dependent manner. Mechanistically, ISO downregulated the expression of the main transcription factor for osteoclast differentiation by inhibiting MAPK and PI3K/AKT1 signaling pathways. Moreover, ISO exhibited protective effects in OVX-induced bone loss rats. This was consistent with the results derived from network pharmacology. Conclusion: Our findings suggest a potential therapeutic utility of ISO in the management of osteoclast-associated bone diseases, including osteoporosis.

9 November 2012 in Journal of Molecular Histology
Verified
Journal Article
Closed access
PDF file
HDHaiying Dong
Haiying Dong
ZJZhenyu Ji
Zhenyu Ji
MLManling Liu
Manling Liu
YWYanxia Wang
Yanxia Wang
XBXiao Bai
Xiao Bai
MDmqdong dong
mqdong dong

24 December 2024 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
JSJinbo Sun
Jinbo Sun
YWYong Wang
Yong Wang
SMShanjin Ma
Shanjin Ma
WZWei Zhang
Wei Zhang
LYLongfei Yang
Longfei Yang
QTQisheng Tang
Qisheng Tang

10 November 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Open access
PDF file
JSJinbo Sun
Jinbo Sun
YWYong Wang
Yong Wang
SMShanjin Ma
Shanjin Ma
WZWei Zhang
Wei Zhang
LYLongfei Yang
Longfei Yang
QTQisheng Tang
Qisheng Tang